According to Lumos Pharma's latest financial reports the company's current EPS (TTM) is -$6.63. In 2022 the company made an earnings per share (EPS) of -$6.50 a decrease over its 2021 EPS that were of -$5.08.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$6.33 | -2.56% |
2022 | -$6.50 | 27.98% |
2021 | -$5.08 | 305.62% |
2020 | -$1.25 | -90.26% |
2019 | -$12.86 | -29.48% |
2018 | -$18.23 | -38.72% |
2017 | -$29.75 | -20.07% |
2016 | -$37.22 | 111.51% |
2015 | -$17.60 | -137.77% |
2014 | $46.59 | -396.77% |
2013 | -$15.70 | 10.71% |
2012 | -$14.18 | 6.4% |
2011 | -$13.33 |